Journal article
An open trial of adjunctive escitalopram in bipolar depression.
Abstract
OBJECTIVE: This study was designed to evaluate the efficacy and safety of a highly potent and selective serotonergic antidepressant, escitalopram, in the treatment of bipolar depression.
METHOD: Twenty outpatients with DSM-IV bipolar depression types I and II were enrolled in a 12-week open trial of escitalopram, 10 mg daily, adjunctive to their ongoing mood stabilizer. Assessments were carried out using the Hamilton Rating Scale for Depression …
Authors
Fonseca M; Soares JC; Hatch JP; Santin AP; Kapczinski F
Journal
The Journal of Clinical Psychiatry, Vol. 67, No. 1, pp. 81–86
Publisher
Physicians Postgraduate Press
Publication Date
January 15, 2006
DOI
10.4088/jcp.v67n0115
ISSN
0160-6689